← Leaderboards
Alan Pollack
Fox Chase Cancer Center
$14,445,128
Attributed
$20,162,043
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,162,043 · 11
By mechanism
R01$10,705,654 · 5
U01$4,277,937 · 2
K12$3,841,240 · 1
R21$1,002,612 · 2
S10$334,600 · 1
Top collaborators
- Radka Stoyanova10 shared
- Sanoj Punnen8 shared
- Sandra M Gaston7 shared
- Robert J Gillies4 shared
- Yoganand Balagurunathan1 shared
- Benjamin Oren Spieler1 shared
Most similar at Fox Chase Cancer Center
Same institution · by research overlap
- Louis M Weiner$35,160,146
- Andrew K Godwin$21,382,895
- Truman R. Brown$14,810,351
- Margie L. Clapper$16,783,564
- Oded Gonen$11,443,774
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsMalignant Neoplasm Of ProstateBiopsyTumorMagnetic Resonance ImagingMalignant NeoplasmsTissuesImageSamplingLesionProstateMolecularGene ExpressionHabitatsCharacteristicsHigh RiskBasePrognosticCancer PatientUniversitiesProtocols DocumentationProstate BiopsyCollaborationsCohort
Grant awards (38)
UM Calabresi Clinical Oncology Research Career Development Award$581,877
K12 · FY2025 · CA · contact PI
Longitudinal Imaging and Liquid Biopsy Markers of Prostate Cancer Radiotherapy Outcomes$538,553
R01 · FY2025 · CA · contact PI
The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection$499,867
R01 · FY2025 · CA
Prostate Needle Biopsies: Impact of Preanalytical Procurement and Processing Variables on the Detection of Gene Expression Signatures of Prostate Cancer Aggressiveness$351,131
U01 · FY2025 · CA · contact PI
UM Calabresi Clinical Oncology Research Career Development Award$764,063
K12 · FY2024 · CA · contact PI
The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection$477,798
R01 · FY2024 · CA
Prostate Needle Biopsies: Impact of Preanalytical Procurement and Processing Variables on the Detection of Gene Expression Signatures of Prostate Cancer Aggressiveness$276,871
U01 · FY2024 · CA · contact PI
UM Calabresi Clinical Oncology Research Career Development Award$720,437
K12 · FY2023 · CA · contact PI
MRI Imaging and Biomarkers for Early Detection of Aggressive Prostate Cancer$557,666
U01 · FY2023 · CA · contact PI
The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection$520,290
R01 · FY2023 · CA
Prostate Needle Biopsies: Impact of Preanalytical Procurement and Processing Variables on the Detection of Gene Expression Signatures of Prostate Cancer Aggressiveness$344,109
U01 · FY2023 · CA · contact PI
MRI Imaging and Biomarkers for Early Detection of Aggressive Prostate Cancer$570,153
U01 · FY2022 · CA · contact PI
Prostate Needle Biopsies: Impact of Preanalytical Procurement and Processing Variables on the Detection of Gene Expression Signatures of Prostate Cancer Aggressiveness$351,131
U01 · FY2022 · CA · contact PI
UM Calabresi Clinical Oncology Research Career Development Award$311,979
K12 · FY2022 · CA · contact PI
UM Calabresi Clinical Oncology Research Career Development Award$715,242
K12 · FY2021 · CA · contact PI
MRI Imaging and Biomarkers for Early Detection of Aggressive Prostate Cancer$592,644
U01 · FY2021 · CA · contact PI
UM Calabresi Clinical Oncology Research Career Development Award$747,642
K12 · FY2020 · CA · contact PI
MRI Imaging and Biomarkers for Early Detection of Aggressive Prostate Cancer$604,709
U01 · FY2020 · CA · contact PI
MRI Imaging and Biomarkers for Early Detection of Aggressive Prostate Cancer$629,523
U01 · FY2019 · CA · contact PI
MRI Imaging and Genetic Signatures to Manage Prostate Cancer Overdiagnosis$560,366
R01 · FY2018 · CA · contact PI
MRI Imaging and Genetic Signatures to Manage Prostate Cancer Overdiagnosis$727,699
R01 · FY2017 · CA · contact PI
(PQC4) Habitats in Prostate Cancer$681,586
R01 · FY2017 · CA
(PQC4) Habitats in Prostate Cancer$682,812
R01 · FY2016 · CA
MRI Imaging and Genetic Signatures to Manage Prostate Cancer Overdiagnosis$596,203
R01 · FY2016 · CA · contact PI
(PQC4) Habitats in Prostate Cancer$692,000
R01 · FY2015 · CA
MRI Imaging and Genetic Signatures to Manage Prostate Cancer Overdiagnosis$615,817
R01 · FY2015 · CA · contact PI
(PQC4) Habitats in Prostate Cancer$730,977
R01 · FY2014 · CA
MRI Imaging and Genetic Signatures to Manage Prostate Cancer Overdiagnosis$667,475
R01 · FY2014 · CA · contact PI
MRI-Guided Radiotherapy and Biomarkers for Prostate Cancer$307,951
R21 · FY2011 · CA · contact PI
MRI-Guided Radiotherapy and Biomarkers for Prostate Cancer$317,475
R21 · FY2010 · CA · contact PI
Biomarker Models of Prostate Cancer Outcome After Radiotherapy$198,806
R21 · FY2010 · CA · contact PI
Biomarker Models of Prostate Cancer Outcome After Radiotherapy$178,380
R21 · FY2009 · CA · contact PI
Radiation, Hormones & Antisense Prostate Cancer Therapy$506,334
R01 · FY2007 · CA · contact PI
Xenogen IVIS-200 Bioluminescent Imaging System$334,600
S10 · FY2007 · RR · contact PI
Radiation, Hormones & Antisense Prostate Cancer Therapy$537,645
R01 · FY2006 · CA · contact PI
Radiation, Hormones &Antisense Prostate Cancer Therapy$576,986
R01 · FY2005 · CA
Radiation, Hormones &Antisense Prostate Cancer Therapy$561,406
R01 · FY2004 · CA
Radiation, Hormones &Antisense Prostate Cancer Therapy$531,840
R01 · FY2003 · CA